New Payment Models For Curative Treatments Have CMS’ Attention, Verma Says

 
• By Cathy Kelly
  
Attention please sign with megaphone - Vector
Concerns over the high cost of Zolgensma prompting 'serious discussions.'
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Government Payers